About this Calculator

The Treprostinil Infusion Calculator is a clinical support tool designed for healthcare professionals to facilitate accurate dosing calculations for treprostinil administered via continuous infusion. It helps convert between a weight-based dose rate (ng/kg/min) and a volumetric infusion rate (mL/hr) based on patient weight and drug concentration. This tool should not replace clinical judgment, and all calculations must be independently verified.

Understanding the Outputs

The calculator provides one of two primary outputs depending on the selected mode:

• Infusion Rate (mL/hr): This is the volumetric rate at which the infusion pump should be set to deliver the desired dose. It is calculated from the patient’s weight, the target dose rate, and the drug concentration.
• Dose Rate (ng/kg/min): This is the normalized, weight-based dose the patient is receiving. It is calculated from the current infusion rate, patient’s weight, and drug concentration. This value is essential for clinical documentation and assessing therapeutic effect.

How to Use the Calculator

1. Select Calculation Mode: Choose whether you want to calculate the infusion rate (mL/hr) from a desired dose or calculate the current dose (ng/kg/min) from a known infusion rate.
2. Enter Patient Weight: Input the patient’s weight. You can use either kilograms (kg) or pounds (lbs); the tool will handle the conversion.
3. Enter Dose or Rate: Based on your selected mode, enter either the desired dose in ng/kg/min or the current infusion rate in mL/hr.
4. Select Drug Concentration: Choose from standard treprostinil concentrations (1, 2.5, 5, or 10 mg/mL) or select “Other” to input a custom concentration for diluted preparations.

The result is calculated automatically. You can also use the “Show Steps” button to review the formula and intermediate values, or “Create Titration Table” to see a range of doses and their corresponding rates.

Dosing Overview

Treprostinil therapy is highly individualized and requires careful initiation and titration under the supervision of a qualified physician.

• Initial Dosing: The recommended starting infusion dose is typically 1.25 ng/kg/min. If this dose is not tolerated, the rate may be reduced to 0.625 ng/kg/min.
• Dose Titration: Doses are generally increased in increments of 1.25 to 2.5 ng/kg/min. For new patients, weekly increases are common during the induction phase. For established patients, dose adjustments may be made every few days as tolerated to achieve clinical goals while managing side effects.
• Administration: Treprostinil can be administered via continuous subcutaneous (SC) or intravenous (IV) infusion. The choice of route depends on clinical factors and patient preference.

Switching

Transitioning a patient to treprostinil from another prostacyclin analogue (e.g., epoprostenol) requires a careful, overlapping titration process in a hospital setting with experienced personnel. The dose of the initial therapy should be gradually reduced while the treprostinil dose is cautiously increased. There is no single validated conversion protocol, and the process must be tailored to the individual patient’s response and tolerability.

Managing a Missed Dose

Due to its short half-life (approximately 4 hours), abrupt withdrawal or a significant reduction in the dose of treprostinil can lead to a rapid worsening of pulmonary hypertension symptoms. It is critical to avoid interruptions in drug delivery. Patients should be educated on pump operation, alarm management, and have access to backup infusion pumps and infusion sets.

Safety Alerts

• Abrupt Withdrawal: Never abruptly discontinue treprostinil infusion. Doing so can cause rebound pulmonary hypertension, leading to dizziness, syncope, and clinical deterioration.
• Infusion Site Infections: For IV administration, there is a significant risk of bloodstream infections related to the central venous catheter. For SC administration, severe infusion site pain and reaction are common. Aseptic technique is paramount.
• Hemodynamic Effects: Treprostinil is a potent vasodilator and can cause symptomatic hypotension. Other common side effects include headache, jaw pain, diarrhea, nausea, and flushing.

Frequently Asked Questions (FAQ)

Why does the calculator need patient weight?

Treprostinil is dosed based on body weight (in nanograms per kilogram per minute). Accurate weight is essential to calculate the correct total dose and corresponding infusion rate.

What’s the difference between the two calculation modes?

The “Calculate mL/hr” mode is used to determine the pump setting when you know the target dose. The “Calculate Dose” mode is used to determine what dose a patient is currently receiving based on their known pump rate.

How do I use the “Custom” concentration option?

Select “Other (Custom)” from the concentration dropdown if you are using a diluted solution of treprostinil. An input field will appear where you can enter the final concentration of your mixture in mg/mL.

Can I use this calculator for subcutaneous (SC) and intravenous (IV) treprostinil?

Yes. The calculations for dose and infusion rate are the same regardless of whether the administration is SC or IV. The concentration of the drug is the key variable.

What do I do if my calculated mL/hr is very low?

At low doses or for pediatric patients, the calculated infusion rate may be very small. It is crucial to ensure your infusion pump can accurately deliver such low volumes. In some cases, the drug may be diluted to a lower concentration to allow for a higher, more reliable infusion volume.

Does this calculator account for drug stability or cassette volume?

No. This tool only performs the dose-to-rate calculation. It does not provide information on drug stability, compatibility with diluents, or the required volume for a specific infusion cassette or syringe. Always refer to the drug’s prescribing information and your institution’s pharmacy protocols.

Why is the titration table useful?

The titration table provides a quick reference for dose adjustments. It shows the corresponding mL/hr rates for doses above and below your target, which helps in planning and executing dose changes safely.

Is this calculator a substitute for programming my infusion pump?

Absolutely not. This is a verification and educational tool. All pump programming must be done carefully according to the manufacturer’s instructions and your institution’s policies, including independent double-checks by a second qualified clinician.

References

• REMODULIN® (treprostinil) Injection – Official FDA Prescribing Information
• United Therapeutics Corporation – Manufacturer Website
• Pharmacologic Therapy for Pulmonary Arterial Hypertension: An Official American Thoracic Society Clinical Practice Guideline – CHEST Journal
• Treprostinil – StatPearls – NCBI Bookshelf